MEET QPS AT THE WORLDSymposium™ 2024; February 4 - 9, SAN DIEGO, CALIFORNIA, USA

5xFAD Transgenic Mouse Model

5xFAD Transgenic Mouse Model

5xFAD (Familiar Alzheimer Disease) mice bear five AD-linked mutations, three in the APP695 gene [APP K670N/M671L (Swedish), I716V (Florida), V717I (London)], and two more mutations in the PSEN1 gene [M146L, L286V]. The expression of the 5xFAD transgene is driven by the neuron-specific Thy1 promoter.

The 5xFAD transgenic mouse model highly overexpresses Aβ1-40 and Aβ1-42 in the brain and cerebrospinal fluid which rapidly increases during aging. Histological analyses of the cortex and hippocampus revealed a dramatic plaque load and β-sheet formation accompanied by strong neuroinflammation. These pathological hallmarks also significantly increase with age. Female 5xFAD mice express slightly more APP than male 5xFAD mice. This difference might be caused by an estrogen response element in the Thy1 promoter. Animals present spatial and long-term memory deficits as analyzed by the Morris water maze. Motor deficits were not detected.

5xFAD mice are thus a suitable model to study the influence of drugs on amyloid production, sequestration and deposition, the involvement of presenilin1 and inflammation.

The most important characteristics of 5xFAD mice are:
  • Increased Aβ in cortex and hippocampus
  • Strong amyloid plaque accumulations
  • Increased neurofilament light chain levels (NF-L)
  • Increased neuroinflammation levels
  • Spatial and long-term memory deficits
5xfad

Figure 1: Aβ42 level in the cortex (A) and hippocampus (B) of 3-, 6- and 9-months old 5xFAD mice. Immunoreactive (IR) area in percent; n = 3. Mean + SEM. One-way ANOVA with Bonferroni’s post hoc test. **p<0.01; ***p<0.001.
 

5xfad

Figure 2 A: Quantification of neurofilament light chain in the plasma of 5xFAD mice. NF-L levels in pg/ml in the plasma of 3-, 6-, 9- and 12-months old 5xFAD mice compared to non-transgenic littermates. Mean + SEM; n = 4-8. Two-way ANOVA with Bonferroni ‘s post hoc test. B: Activated microglia in the cortex of 3-, 6- and 9-months old 5xFAD mice. Immunoreactive area in percent in the cortex; n = 3. Mean + SEM. One Way ANOVA with Bonferroni’s post hoc test. *p<0.05; **p<0.01; ***p<0.001.
 
QPS Neuropharmacology offers a custom-tailored study design for 5xFAD mice, and we are flexible to accommodate your special interests. We are also happy to advise you and propose study designs. 5xFAD mice show relevant features of AD already at 6 months of age. Based on various options to study 5xFAD mice, your study will be customized according to your requirements. Furthermore, non-transgenic littermates are available as control animals needed for proper study design.

We are happy to evaluate the efficacy of your compound in the 5xFAD mouse model! The most common readouts are:

You might also be interested in these related topics:

We are happy to receive your inquiry.

In Vitro Services

QPS Neuropharmacology provides research services with numerous standardized cell culture systems including transgenic and non-transgenic cell lines, glial cells, primary chicken and rat peripheral and central nervous system neurons of different developmental stages and organotypic brain slices. New models are developed and validated on request.
LEARN MORE

In Vivo Services

As a leading CRO for CNS drug development, QPS Neuropharmacology is the premier provider for services with transgenic animals. We have more than 20 years of experience in generating, characterizing, and maintaining transgenic disease models and applying them for drug testing projects.
LEARN MORE

Ex Vivo Services

QPS Neuropharmacology's expertise lies within the field of neurodegenerative diseases. We provide a state of the art research environment (AAALAC certified) for testing and evaluating new potential treatment approaches.
LEARN MORE

Biobank

QPS Neuropharmacology's well characterized and validated in vivo models are useful tools to push your CNS drug discovery research forward. We are happy to support your research activities with sample material from our biobank composed of various specimen derived from our in-house in vivo models.
LEARN MORE

animal models

QPS Neuropharmacology is highly experienced in generating, characterizing, and maintaining transgenic disease models and using them for drug testing projects for more than 20 years.
LEARN MORE

behavioral testing

QPS Neuropharmacology provides a wide range of behavioral tests for various indications. Most tests are evaluated using rater-independent digital animal tracking systems.
LEARN MORE

histology services

QPS Neuropharmacology offers a full set of histology services ranging from collection of tissue samples to delivering study reports that contain all experimental procedures and their outcome.
LEARN MORE

biomarkers

QPS Neuropharmacology Department of Translational Medicine offers a selection of molecular biological methods for the investigation of various diseases. The unit supports in vitro and in vivo studies performed at QPS Austria.
LEARN MORE